Skip to main content

Table 2 KOOS changes between the follow-up visits (T3 and T1) and baseline FAS population

From: Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study

 

BCL high dose, mean ± SD

BCL low dose, mean ± SD

Placebo, mean ± SD

KOOS change at T1 (difference between T1 and baseline)

N

49

46

45

Global score

35.2 ± 67.5

18.0 ± 57.6

7.9 ± 60.2

Pain

7.1 ± 17.5

4.8 ± 16.7

3.1 ± 13.9

Symptoms

6.7 ± 15.2

2.9 ± 13.6

1.7 ± 14.6

Function in daily living (ADL)

5.9 ± 19.6

4.0 ± 16.5

1.4 ± 13.2

Function in sport and recreation (sport/rec)

10.5 ± 18.0

4.2 ± 16.7

2.3 ± 15.4

Knee-related quality of life (QoL)

5.6 ± 14.8

3.1 ± 14.9

− 0.2 ± 16.2

KOOS change at T3 (difference between T3 and baseline)

N

47

38

40

Global score

56.3 ± 82.6

48. ± 73.1

42.1 ± 66.2

Pain

12.3 ± 19.4

12.8 ± 18.4

10.8 ± 16.5

Symptoms

10.0 ± 16.6

7.4 ± 16.0

7.5 ± 14.7

Function in daily living (ADL)

9.2 ± 19.5

10.3 ± 20.9

7.3 ± 14.6

Function in sport and recreation (sport/rec)

11.1 ± 20.5

9.6 ± 15.3

9.7 ± 17. 8

Knee related quality of life (QoL)

12.4 ± 20.3

9.2 ± 19.3

6.6 ± 16.8